Search results for "Movement Disorders"

showing 10 items of 74 documents

A quantitative study of the pancuronium antagonism at the motor endplate in human organophosphorus intoxication

1995

Nine patients with organophosphorus (OP) intoxication developing neuromuscular transmission defects were given pancuronium 1, 2, or 4 mg intravenously (IV). Thirteen patient controls with hypoxic encephalopathy received similar dosages. The responses were monitored electrophysiologically using single and repetitive nerve stimulation (20 and 50 Hz). In OP patients, pancuronium did not alter the amplitude of the single CMAP, whereas its repetitive discharges were reduced. Severe neuromuscular blocks were reversed only partially by pancuronium 4 mg. In less severe blocks, 1 and 2 mg resulted in marked improvement. In the patient controls, pancuronium 4 mg induced a severe neuromuscular block b…

AdultTime FactorsPhysiologymedicine.medical_treatmentNeuromuscular transmissionAction PotentialsElectromyographyMotor EndplateSynaptic TransmissionNeuromuscular junctionCellular and Molecular Neurosciencechemistry.chemical_compoundOrganophosphate PoisoningPhysiology (medical)medicineHumansPancuroniumRepetitive nerve stimulationAntidoteNeuromuscular BlockadeMovement DisordersDose-Response Relationship Drugmedicine.diagnostic_testbusiness.industryNeuromuscular DiseasesAcetylcholinesteraseElectric Stimulationmedicine.anatomical_structurechemistryAnesthesiaInjections IntravenousToxicityAcetylcholinesteraseNeurology (clinical)businessMuscle & Nerve
researchProduct

Magnetic resonance imaging of postrepair-myelomeningocele — findings in 31 children and adolescents

1987

Magnetic resonance imaging has clearly demonstrated its efficacy in the diagnosis of pathological processes in the C.N.S. We examined 31 children who had undergone plastic closure of myelomeningocele a few days post partum. We could show that a high percentage of the patients (89%) presented the pathological anatomy of a tethered spinal cord; clinical symptoms of the tethered spinal cord syndrome, i.e. progressive neurological symptoms, however, are rarely observed. Possible revision of neurosurgical treatment of MMC is discussed.

Adultmedicine.medical_specialtyMeningomyeloceleAdolescentSensationSpinal Cord DiseasesPostoperative ComplicationsHumansMedicineSpinal Cord NeoplasmsChildPathologicalPost partumMovement Disordersmedicine.diagnostic_testCystsbusiness.industryMagnetic resonance imagingGeneral MedicineTethered spinal cord syndromemedicine.diseasePathological anatomySpinal cordMagnetic Resonance ImagingSurgerymedicine.anatomical_structureEl NiñoChild PreschoolSurgeryLipomaNeurology (clinical)NeurosurgerybusinessSpinal Cord CompressionNeurosurgical Review
researchProduct

Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?.

2006

The basal ganglia are a highly interconnected group of subcortical nuclei in the vertebrate brain that play a critical role not only in the control of movements but also in some cognitive and behavioral functions. Several recent studies have emphasized that serotonergic pathways in the central nervous system (CNS) are intimately involved in the modulation of the basal ganglia and in the pathophysiology of human involuntary movement disorders. These observations are supported by anatomical evidence demonstrating large serotonergic innervation of the basal ganglia. In fact, serotonergic terminals have been reported to make synaptic contacts with dopamine (DA)-containing neurons and gamma-amin…

Central Nervous SystemSerotoninmedicine.medical_specialtySubstantia nigraBiologyIndirect pathway of movementSerotonergicBiochemistrySerotonin AgentsBasal Ganglia DiseasesDopamineInternal medicineSerotonin AgentsDrug DiscoveryBasal gangliaReceptor Serotonin 5-HT2CmedicineAnimalsHumansBasal ganglia diseasegamma-Aminobutyric AcidNeuronsPharmacologyMovement DisordersOrganic ChemistryParkinson Diseasemedicine.diseasebasal ganglion pathophysiology Basal Ganglia Diseases pathophysiologyGlobus pallidusEndocrinologynervous systemSynapsesMolecular Medicinemedicine.drug
researchProduct

Complex regional pain syndrome–up-to-date

2017

The pathophysiology of complex regional pain syndromes includes inflammation and central reorganisation. The treatment should be adjusted to the prevailing pathophysiology including possible psychosocial factors.

Central reorganisationmedicine.medical_specialtyMovement disorderslcsh:RD78.3-87.303 medical and health sciences0302 clinical medicinemedicineKetamine030212 general & internal medicineIntensive care medicinebusiness.industryChronic painPAIN Clinical Updates14Sensory lossmedicine.diseaseComplex regional pain syndrome3. Good healthTreatmentAnesthesiology and Pain MedicineNociceptionComplex regional pain syndromePosttraumatic inflammationlcsh:AnesthesiologyHyperalgesiaNeuroplasticitymedicine.symptombusinessPsychosocial030217 neurology & neurosurgerymedicine.drugPAIN Reports
researchProduct

Clinical spectrum of movement disorders after stroke in childhood and adulthood.

2011

Although rare, many different types of hyperkinetic and hypokinetic movement disorders have been described after both ischemic and hemorrhagic stroke in children and in adults. Current knowledge about these disorders comes from single case reports or small series of cases compiled from retrospective studies. Data from hospital-based studies suggest a prevalence of poststroke movement disorders ranging from 1.1 to 3.9%. However, despite the development of emergency care for stroke, these clinical syndromes remain insufficiently recognized. Poststroke movement disorders take place in the acute phase or following a variable delay after stroke onset, and could be transient or persistent. Dyston…

DystoniaAdultmedicine.medical_specialtyPediatricsMovement disordersMovement Disordersbusiness.industryChoreaRetrospective cohort studymedicine.diseaseStrokeNeurologyBasal gangliaPhysical therapymedicineHumansNeurology (clinical)medicine.symptombusinessChildStrokeMyoclonusAsterixisEuropean neurology
researchProduct

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

2021

Background and ObjectivesAnti-IgLON5 disease is a recently described neurologic disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are underreported. We describe the frequency and types of movement disorders in a series of consecutive patients with this disease.MethodsIn this retrospective, observational study, the presence and phenomenology of movement disorders were assessed with a standardized clinical questionnaire. Available videos were centrally reviewed by 3 experts in movement disorders.ResultsSeventy-two patients were included. In 41 (57%), the main reason for initial consult…

DystoniaPediatricsmedicine.medical_specialtyAtaxiaMovement disordersbusiness.industryautoimmunityAnti-IgLON5neurodegenerationChoreamedicine.diseaseAkathisianervous system diseasesmedicineBody regionHuman medicineNeurology (clinical)Myokymiamedicine.symptombusinessMyoclonusResearch Article
researchProduct

Factors influencing psychological well-being in patients with Parkinson's disease.

2017

Background Both motor and non-motor symptoms could contribute to significant deterioration of psychological well-being in patients with Parkinson's disease (PD). However, its assessment has been only indirectly evaluated using tools based on health-related quality of life (HRQoL), such as the PDQ-39 scale. Objectives To evaluate psychological well-being in PD using a specific tool of assessment, the Psychological Well-being Scale (PWS), and its clinical correlates. Methods This article reports data of patients' perception of health state, as measured by means of the PWS, from an epidemiological, cross-sectional study conducted in Italian PD patients (FORTE Study). We tested possible relatio…

Genetics and Molecular Biology (all)MaleParkinson's diseaseEmotionsPoison controlSocial Scienceslcsh:MedicinePathology and Laboratory MedicineBiochemistrySeverity of Illness IndexAged; Depression; Fatigue; Female; Humans; Italy; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)0302 clinical medicineMathematical and Statistical TechniquesQuality of lifeSurveys and QuestionnairesMedicine and Health SciencesMedicinePsychologySurveys and Questionnaire030212 general & internal medicinelcsh:ScienceDepression (differential diagnoses)FatigueMultidisciplinaryMovement DisordersDepressionNeurodegenerative DiseasesParkinson DiseaseMiddle AgedPsychiatric Status Rating ScalehumanitiesNeurologyItalyPhysical SciencesFemaleStatistics (Mathematics)Clinical psychologyResearch ArticleHumanResearch and Analysis Methods03 medical and health sciencesSigns and SymptomsDiagnostic MedicineSeverity of illnessInjury preventionMental Health and PsychiatryHumansStatistical MethodsAgedPsychiatric Status Rating Scalesparkinson's disease quality of lifeAnalysis of VarianceBiochemistry Genetics and Molecular Biology (all)business.industryMood Disorderslcsh:RBeck Depression InventoryBiology and Life Sciencesmedicine.diseaseHealth CareAgricultural and Biological Sciences (all)Psychological well-beingAged; Depression; Fatigue; Female; Humans; Italy; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and QuestionnairesQuality of Lifelcsh:QbusinessSleep Disorders030217 neurology & neurosurgeryMathematicsPLoS ONE
researchProduct

Mobility difficulties and physical activity as predictors of mortality and loss of independence in the community-living older population.

2000

OBJECTIVE: In older people, mobility impairments and physical inactivity are risk factors for further disability and death. We studied the interaction of physical activity and mobility impairment as a predictor of dependence and mortality. DESIGN: A population-based, prospective study. The data were collected in structured interviews in the year 1988 and 8 years later in the year 1996 as part of the Evergreen Project. PARTICIPANTS: Subjects were 1109 independently living, at baseline 65- to 84-year-old people in the city of Jyvaskyla, in central Finland. METHODS: Participants were ranked into four groups: (1) Intact mobility and physically active (Mobile-Active), (2) Intact mobility and sed…

GerontologyMaleAgingActivities of daily livingPopulationPhysical exerciseActivities of Daily LivingMedicineHumansProspective StudiesMortalityeducationExerciseGeriatric AssessmentFinlandAgedProportional Hazards ModelsAged 80 and overeducation.field_of_studyMovement Disordersbusiness.industryConfoundingConfounding Factors EpidemiologicOdds ratioConfidence intervalRelative riskPopulation SurveillanceMarital statusFemaleGeriatrics and Gerontologybusiness
researchProduct

Reduced mobility and physical activity as predictors of depressive symptoms among community-dwelling older adults: an eight-year follow-up study.

2003

Background and aims: Epidemiological research suggests that reduced physical activity and mobility may be associated with depressive symptoms. The present study examines the relative roles of mobility status and physical activity as predictors of depressive symptoms among community-dwelling older adults. Methods: The subjects comprised randomly selected, non-institutionalized residents of the city of Jyvaskyla, central Finland, born in 1904–1923. At baseline, 80% (N=1224) and after the 8-year follow-up period (1996) 88% (N=663) of eligible persons were interviewed. All non-institutionalized men and women (N=384) who participated in both baseline and follow-up interviews, who supplied data o…

GerontologyMaleAgingmedicine.medical_specialtyDepression scalePhysical activityWalkingMotor ActivityMobility statusEpidemiologymedicineElderly peopleHumansLife StyleDepressive symptomsAgedMovement DisordersDepressionFollow up studiesReduced mobilityPrognosisLogistic ModelsFemaleGeriatrics and GerontologyPsychologyFollow-Up StudiesAging clinical and experimental research
researchProduct

Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism.

2022

Background Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodegeneration. Objectives The aim of this study was to deeply characterize phenogenotypically PLA2G6-related parkinsonism in the largest cohort ever reported. Methods We report 14 new cases of PLA2G6-related parkinsonism and perform a systematic literature review. Results PLA2G6-related parkinsonism shows a fairly distinct phenotype based on 86 cases from 68 pedigrees. Young onset (median age, 23.0 years) with parkinsonism/dystonia, gait/balance, and/or psychiatric/cognitive symptoms were common presenting features. Dystonia occurred in 69.4%, pyramidal signs in 77.2%, myoclonus in 65.2%, and cere…

LevodopaPediatricsmedicine.medical_specialtyMovement disordersDeep brain stimulationGenotypemedicine.medical_treatmentPLANPLA2G6Group VI Phospholipases A2Atrophysystematic reviewParkinsonian DisordersmedicineHumansAge of OnsetparkinsonismDystoniaNBIAbusiness.industryParkinsonismmedicine.diseasenervous system diseasesPedigreeDystoniaPhenotypeNeurologyMutationCerebellar atrophyNeurology (clinical)medicine.symptomAtrophybusinessMyoclonusmedicine.drugMovement disorders : official journal of the Movement Disorder SocietyReferences
researchProduct